Jailendra Singh
Stock Analyst at Truist Securities
(0.86)
# 3,916
Out of 5,005 analysts
184
Total ratings
25.77%
Success rate
-22.51%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHR Phreesia | Maintains: Buy | $35 → $36 | $23.27 | +54.71% | 7 | Sep 8, 2025 | |
| HIMS Hims & Hers Health | Maintains: Hold | $48 → $37 | $52.54 | -29.58% | 11 | Aug 18, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $187 → $234 | $193.89 | +20.69% | 10 | Jul 25, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $298 → $436 | $532.49 | -18.12% | 5 | Jul 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $209 → $235 | $206.63 | +13.73% | 16 | Jul 23, 2025 | |
| WAY Waystar Holding | Maintains: Buy | $50 → $51 | $38.64 | +31.99% | 3 | Jul 17, 2025 | |
| PGNY Progyny | Maintains: Hold | $24 → $27 | $20.59 | +31.13% | 10 | Jul 17, 2025 | |
| EVH Evolent Health | Maintains: Buy | $14 → $16 | $8.23 | +94.41% | 6 | Jul 17, 2025 | |
| DOCS Doximity | Maintains: Hold | $52 → $61 | $73.26 | -16.73% | 9 | Jul 17, 2025 | |
| HNGE Hinge Health | Initiates: Buy | $48 | $51.29 | -6.41% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $10 → $9 | $9.01 | -0.11% | 16 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $28 | $24.09 | +16.23% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.5 → $5.5 | $4.53 | +21.41% | 12 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $12 → $7.5 | $6.33 | +18.48% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $46 | $28.75 | +60.00% | 5 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $261 → $210 | $296.28 | -29.12% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $10.91 | +28.32% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.4 → $6.5 | $1.13 | +475.22% | 8 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $13 | $4.44 | +192.79% | 11 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $43 | $4.76 | +803.36% | 6 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $24 | $3.42 | +601.75% | 2 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $4 | $2.10 | +90.48% | 4 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $58 | $154.46 | -62.45% | 2 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $90 → $45 | $4.72 | +853.39% | 7 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $230 → $333 | $738.06 | -54.88% | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9 | $2.59 | +247.49% | 2 | May 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $27.90 | - | 3 | Jan 15, 2021 |
Phreesia
Sep 8, 2025
Maintains: Buy
Price Target: $35 → $36
Current: $23.27
Upside: +54.71%
Hims & Hers Health
Aug 18, 2025
Maintains: Hold
Price Target: $48 → $37
Current: $52.54
Upside: -29.58%
ICON Public Limited Company
Jul 25, 2025
Maintains: Buy
Price Target: $187 → $234
Current: $193.89
Upside: +20.69%
Medpace Holdings
Jul 23, 2025
Maintains: Hold
Price Target: $298 → $436
Current: $532.49
Upside: -18.12%
IQVIA Holdings
Jul 23, 2025
Maintains: Buy
Price Target: $209 → $235
Current: $206.63
Upside: +13.73%
Waystar Holding
Jul 17, 2025
Maintains: Buy
Price Target: $50 → $51
Current: $38.64
Upside: +31.99%
Progyny
Jul 17, 2025
Maintains: Hold
Price Target: $24 → $27
Current: $20.59
Upside: +31.13%
Evolent Health
Jul 17, 2025
Maintains: Buy
Price Target: $14 → $16
Current: $8.23
Upside: +94.41%
Doximity
Jul 17, 2025
Maintains: Hold
Price Target: $52 → $61
Current: $73.26
Upside: -16.73%
Hinge Health
Jun 16, 2025
Initiates: Buy
Price Target: $48
Current: $51.29
Upside: -6.41%
May 27, 2025
Maintains: Hold
Price Target: $10 → $9
Current: $9.01
Upside: -0.11%
Apr 10, 2025
Maintains: Buy
Price Target: $27 → $28
Current: $24.09
Upside: +16.23%
Apr 10, 2025
Maintains: Hold
Price Target: $6.5 → $5.5
Current: $4.53
Upside: +21.41%
Apr 10, 2025
Maintains: Hold
Price Target: $12 → $7.5
Current: $6.33
Upside: +18.48%
Mar 18, 2025
Maintains: Buy
Price Target: $50 → $46
Current: $28.75
Upside: +60.00%
Jan 13, 2025
Maintains: Hold
Price Target: $261 → $210
Current: $296.28
Upside: -29.12%
Jul 2, 2024
Maintains: Buy
Price Target: $17 → $14
Current: $10.91
Upside: +28.32%
May 24, 2024
Maintains: Hold
Price Target: $6.4 → $6.5
Current: $1.13
Upside: +475.22%
May 4, 2022
Maintains: Neutral
Price Target: $16 → $13
Current: $4.44
Upside: +192.79%
Feb 28, 2022
Maintains: Neutral
Price Target: $42 → $43
Current: $4.76
Upside: +803.36%
Feb 24, 2022
Maintains: Neutral
Price Target: $30 → $24
Current: $3.42
Upside: +601.75%
Feb 8, 2022
Downgrades: Neutral
Price Target: $14 → $4
Current: $2.10
Upside: +90.48%
Feb 4, 2022
Maintains: Neutral
Price Target: $60 → $58
Current: $154.46
Upside: -62.45%
Jan 7, 2022
Downgrades: Underperform
Price Target: $90 → $45
Current: $4.72
Upside: +853.39%
Jan 7, 2022
Upgrades: Outperform
Price Target: $230 → $333
Current: $738.06
Upside: -54.88%
May 19, 2021
Maintains: Neutral
Price Target: $10 → $9
Current: $2.59
Upside: +247.49%
Jan 15, 2021
Downgrades: Underperform
Price Target: n/a
Current: $27.90
Upside: -